Last reviewed · How we verify

NCT03508674

Prospective Study of Liver Mobilization With the Levita Magnetic Surgical System

Completed NA Results posted Last updated 16 October 2024
What this trial tests

NA trial testing Levita Magnetic Surgical System in Bariatric Surgery Candidate in 54 participants. Completed in 6 September 2018.

Timeline
20 April 2018
Primary endpoint
6 September 2018
6 September 2018

Quick facts

Lead sponsorLevita Magnetics
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment54
Start date20 April 2018
Primary completion6 September 2018
Estimated completion6 September 2018
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

Levita Magnetics — full company profile →

Who can join

18 and older, any sex, with Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number and Types of Additional Tools Required to Mobilize the Liver During Procedure Primary · During planned bariatric procedure. (approximately 2 hours on a single day.)

The ability to mobilize the liver will be evaluated by recording the number and types of additional tools used to mobilize the liver during a bariatric procedure. If another tool besides the Magnetic Surgical System (MSS) is required to move the liver then the use of the MSS has not been successful.

GroupValue95% CI
Intervention0
Number of Participants With Adverse Events and Device Related Adverse Events Primary · Through 30 days post bariatric procedure

All adverse events will be recorded and allocated as to relatedness to device, procedure or other.

Total Participants With Adverse Events
GroupValue95% CI
Intervention17
Participants With Adverse Events Related to Device
GroupValue95% CI
Intervention14

Adverse events — posted to ClinicalTrials.gov

Time frame: 30 days. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Intervention
Serious: 2/54 (4%)
Deaths: 0/54

Serious adverse events (2 terms)

ReactionSystemIntervention
MiscarriagePregnancy, puerperium and perinatal conditions
Abdominal Pain and VomitingGastrointestinal disorders
Other adverse events (6 terms — click to expand)

ReactionSystemIntervention
PetechiaeSkin and subcutaneous tissue disorders
Liver Capsule Superficial Erosion Without BleedingHepatobiliary disorders
Liver Capsule Superficial Abrasion Without BleedingHepatobiliary disorders
EcchymosisSkin and subcutaneous tissue disorders
Hepatic HematomaHepatobiliary disorders
Acute GastroenteritisGastrointestinal disorders

Most-reported serious reactions: Miscarriage, Abdominal Pain and Vomiting.

Data from ClinicalTrials.gov NCT03508674 adverse events section.

Sponsor's own description

The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System in patients undergoing bariatric procedures

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Levita Magnetic Surgical System

Trials testing the same drug.

Other recruiting trials for Bariatric Surgery Candidate

Currently open trials in the same condition.

Other Levita Magnetics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03508674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing